These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Isoflavones derived from soy beans prevent MuRF1-mediated muscle atrophy in C2C12 myotubes through SIRT1 activation. Hirasaka K; Maeda T; Ikeda C; Haruna M; Kohno S; Abe T; Ochi A; Mukai R; Oarada M; Eshima-Kondo S; Ohno A; Okumura Y; Terao J; Nikawa T J Nutr Sci Vitaminol (Tokyo); 2013; 59(4):317-24. PubMed ID: 24064732 [TBL] [Abstract][Full Text] [Related]
3. Blockade of forkhead box protein O1 signaling alleviates primary sclerosing cholangitis-induced sarcopenia in mice model. Kim DH; Kim J; Park J; Kim TH; Han YH Life Sci; 2024 Nov; 356():123042. PubMed ID: 39233198 [TBL] [Abstract][Full Text] [Related]
4. Resveratrol prevents TNF-α-induced muscle atrophy via regulation of Akt/mTOR/FoxO1 signaling in C2C12 myotubes. Wang DT; Yin Y; Yang YJ; Lv PJ; Shi Y; Lu L; Wei LB Int Immunopharmacol; 2014 Apr; 19(2):206-13. PubMed ID: 24534773 [TBL] [Abstract][Full Text] [Related]
5. RANKL Mediates Muscle Atrophy and Dysfunction in a Cigarette Smoke-induced Model of Chronic Obstructive Pulmonary Disease. Xiong J; Le Y; Rao Y; Zhou L; Hu Y; Guo S; Sun Y Am J Respir Cell Mol Biol; 2021 May; 64(5):617-628. PubMed ID: 33689672 [TBL] [Abstract][Full Text] [Related]
7. Mountain ginseng inhibits skeletal muscle atrophy by decreasing muscle RING finger protein-1 and atrogin1 through forkhead box O3 in L6 myotubes. Seok YM; Yoo JM; Nam Y; Kim J; Kim JS; Son JH; Kim HJ J Ethnopharmacol; 2021 Apr; 270():113557. PubMed ID: 33161026 [TBL] [Abstract][Full Text] [Related]
8. Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes. Castillero E; Alamdari N; Lecker SH; Hasselgren PO Metabolism; 2013 Oct; 62(10):1495-502. PubMed ID: 23866982 [TBL] [Abstract][Full Text] [Related]
9. Cryptotanshinone prevents muscle wasting in CT26-induced cancer cachexia through inhibiting STAT3 signaling pathway. Chen L; Yang Q; Zhang H; Wan L; Xin B; Cao Y; Zhang J; Guo C J Ethnopharmacol; 2020 Oct; 260():113066. PubMed ID: 32505837 [TBL] [Abstract][Full Text] [Related]
10. Identification of a KLF5-dependent program and drug development for skeletal muscle atrophy. Liu L; Koike H; Ono T; Hayashi S; Kudo F; Kaneda A; Kagechika H; Manabe I; Nakashima T; Oishi Y Proc Natl Acad Sci U S A; 2021 Aug; 118(35):. PubMed ID: 34426497 [TBL] [Abstract][Full Text] [Related]
11. Involvement of the FoxO1/MuRF1/Atrogin-1 Signaling Pathway in the Oxidative Stress-Induced Atrophy of Cultured Chronic Obstructive Pulmonary Disease Myotubes. Pomiès P; Blaquière M; Maury J; Mercier J; Gouzi F; Hayot M PLoS One; 2016; 11(8):e0160092. PubMed ID: 27526027 [TBL] [Abstract][Full Text] [Related]
12. Vigeo Promotes Myotube Differentiation and Protects Dexamethasone-Induced Skeletal Muscle Atrophy via Regulating the Protein Degradation, AKT/mTOR, and AMPK/Sirt-1/PGC1α Signaling Pathway In Vitro and In Vivo. Cheon YH; Lee CH; Chung CH; Kim JY; Lee MS Nutrients; 2024 Aug; 16(16):. PubMed ID: 39203823 [TBL] [Abstract][Full Text] [Related]
13. 20(s)‑ginseonside‑Rg3 modulation of AMPK/FoxO3 signaling to attenuate mitochondrial dysfunction in a dexamethasone‑injured C2C12 myotube‑based model of skeletal atrophy Wang M; Jiang R; Liu J; Xu X; Sun G; Zhao D; Sun L Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33649814 [TBL] [Abstract][Full Text] [Related]
15. Pyropia yezoensis peptide PYP1‑5 protects against dexamethasone‑induced muscle atrophy through the downregulation of atrogin1/MAFbx and MuRF1 in mouse C2C12 myotubes. Lee MK; Kim YM; Kim IH; Choi YH; Nam TJ Mol Med Rep; 2017 Jun; 15(6):3507-3514. PubMed ID: 28393223 [TBL] [Abstract][Full Text] [Related]
16. Oncostatin M induces C2C12 myotube atrophy by modulating muscle differentiation and degradation. Miki Y; Morioka T; Shioi A; Fujimoto K; Sakura T; Uedono H; Kakutani Y; Ochi A; Mori K; Shoji T; Emoto M; Inaba M Biochem Biophys Res Commun; 2019 Aug; 516(3):951-956. PubMed ID: 31272716 [TBL] [Abstract][Full Text] [Related]
17. Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study. Yuan L; Han J; Meng Q; Xi Q; Zhuang Q; Jiang Y; Han Y; Zhang B; Fang J; Wu G Oncol Rep; 2015 May; 33(5):2261-8. PubMed ID: 25760630 [TBL] [Abstract][Full Text] [Related]
18. HucMSCs Delay Muscle Atrophy After Peripheral Nerve Injury Through Exosomes by Repressing Muscle-Specific Ubiquitin Ligases. Chen J; Zhu Y; Gao H; Chen X; Yi D; Li M; Wang L; Xing G; Chen S; Tang J; Wang Y Stem Cells; 2024 May; 42(5):460-474. PubMed ID: 38381592 [TBL] [Abstract][Full Text] [Related]
19. Lee MK; Choi YH; Nam TJ Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 33955507 [TBL] [Abstract][Full Text] [Related]
20. Lee HY; Lee J; Lim H; Kim HY; Koo YS; Lim JS; Yoon Y J Med Food; 2024 May; 27(5):385-395. PubMed ID: 38574296 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]